These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16465517)

  • 21. Evidence and evidence gaps - an introduction.
    Dreier G; Löhler J
    GMS Curr Top Otorhinolaryngol Head Neck Surg; 2016; 15():Doc11. PubMed ID: 28025611
    [No Abstract]   [Full Text] [Related]  

  • 22. Practical tools and methods for health technology assessment in Europe: structures, methodologies, and tools developed by the European Network for Health Technology Assessment, EUnetHTA.
    Kristensen FB; Lampe K; Chase DL; Lee-Robin SH; Wild C; Moharra M; Garrido MV; Nielsen CP; Røttingen JA; Neikter SA; Bistrup ML;
    Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():1-8. PubMed ID: 20030885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of drug listing recommendations and the decision-making process in Australia, the Netherlands, Sweden, and the UK.
    Salas-Vega S; Bertling A; Mossialos E
    Health Policy; 2016 Oct; 120(10):1104-1114. PubMed ID: 27665497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [From evidence-based medicine to medicine-based evidence].
    González De Dios J
    An Esp Pediatr; 2001 Nov; 55(5):429-39. PubMed ID: 11696308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using health technology assessment to identify gaps in evidence and inform study design for comparative effectiveness research.
    Tunis SR; Turkelson C
    J Clin Oncol; 2012 Dec; 30(34):4256-61. PubMed ID: 23071248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence-based decision-making 3: Health technology assessment.
    O'Reilly D; Campbell K; Vanstone M; Bowen JM; Schwartz L; Assasi N; Goeree R
    Methods Mol Biol; 2015; 1281():417-41. PubMed ID: 25694325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence-based medicine for orthopedic practice.
    Akai M
    J Orthop Sci; 2002; 7(6):731-42. PubMed ID: 12486483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Values and evidence colliding: health technology assessment in child health.
    Ungar WJ; Prosser LA; Burnett HF
    Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):417-9. PubMed ID: 23977967
    [No Abstract]   [Full Text] [Related]  

  • 29. Network evaluation: principles, structures and outcomes of the German working group of Health Promoting Universities.
    Stock C; Milz S; Meier S
    Glob Health Promot; 2010 Mar; 17(1):25-32. PubMed ID: 20357349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ["Best practice" in health care--or why we need evidence-based medicine, guidelines and health technology assessment].
    Perleth M; Jakubowski E; Busse R
    Z Arztl Fortbild Qualitatssich; 2000 Oct; 94(9):741-4. PubMed ID: 11127781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug delivery system innovation and Health Technology Assessment: Upgrading from Clinical to Technological Assessment.
    Panzitta M; Bruno G; Giovagnoli S; Mendicino FR; Ricci M
    Int J Pharm; 2015 Nov; 495(2):1005-18. PubMed ID: 26399633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence-Based Decision Making 3: Health Technology Assessment.
    O'Reilly D; Audas R; Campbell K; Vanstone M; Bowen JM; Schwartz L; Assasi N; Goeree R
    Methods Mol Biol; 2021; 2249():429-454. PubMed ID: 33871857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methodology of "Physical and Rehabilitation Medicine practice, Evidence Based Position Papers: the European position" produced by the UEMS-PRM Section.
    Negrini S; Kiekens C; Zampolini M; Wever D; Varela Donoso E; Christodoulou N
    Eur J Phys Rehabil Med; 2016 Feb; 52(1):134-41. PubMed ID: 26681647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of health technology assessment in Lithuania.
    Danguole J
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():140-2. PubMed ID: 19575824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stakeholders involvement by HTA Organisations: why is so different?
    Cavazza M; Jommi C
    Health Policy; 2012 May; 105(2-3):236-45. PubMed ID: 22364715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. History of health technology assessment in Belgium.
    Cleemput I; Van Wilder P
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():82-7. PubMed ID: 19500438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is 'best practice' in health care? State of the art and perspectives in improving the effectiveness and efficiency of the European health care systems.
    Perleth M; Jakubowski E; Busse R
    Health Policy; 2001 Jun; 56(3):235-50. PubMed ID: 11399348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pedagogic reflexions on the evidence-based medicine curriculum of the German Central Agency for Quality in Medicine and the German Network for Evidence-Based Medicine].
    Meyer G; Schlömer G
    Z Arztl Fortbild Qualitatssich; 2003 Jul; 97(4-5):287-90. PubMed ID: 12891971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doing more harm than good? Do systematic reviews of PET by health technology assessment agencies provide an appraisal of the evidence that is closer to the truth than the primary data supporting its use?
    Ware RE; Hicks RJ
    J Nucl Med; 2011 Dec; 52 Suppl 2():64S-73S. PubMed ID: 22144557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EBM, HTA, and CER: clearing the confusion.
    Luce BR; Drummond M; Jönsson B; Neumann PJ; Schwartz JS; Siebert U; Sullivan SD
    Milbank Q; 2010 Jun; 88(2):256-76. PubMed ID: 20579285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.